Page 41 - Read Online
P. 41

Page 6 of 7              Donate et al. Rare Dis Orphan Drugs J 2023;2:4  https://dx.doi.org/10.20517/rdodj.2023.02

               may include a list of questions to ask at clinic visits and promulgation of the “transition passport” that was
                                                               [16]
               developed so that patients can anticipate their care needs . This approach may be more likely to succeed if
               the educational materials are made available in Spanish and are paired with outreach to primary care
                                                                        [13]
               providers that reinforce guideline-directed care of patients with TS . We plan to utilize these strategies in
               future clinical encounters. A nationwide collaborative network of Turner syndrome clinics, including the
               Turner Syndrome Adult Comprehensive Care Center at UTHealth Houston, is well positioned to lead these
               efforts.


               Limitations: Patient-reported data is subject to recall bias. Subgroup analysis of non-White participants is
               not possible because they were significantly underrepresented in our survey.


               DECLARATIONS
               Acknowledgments
               We are profoundly grateful to the patients and families who participate in the UTHealth Turner Syndrome
               Research Registry. Tatianna Contreras, Joana Castillo Di Giaciento, and Sandra Lopez-Lugo assisted with
               patient outreach and data abstraction for this study.

               Authors’ contributions
               Analyzed the data and drafted the manuscript: Donate P
               Designed the study and edited the manuscript: Rivera-Davila M, Prakash SK


               Availability of data and materials
               Not applicable.


               Financial support and sponsorship
               This work was funded in part by a gift from the Turner Syndrome Society of the United States.

               Conflicts of interest
               All authors declare no conflicts of interest.

               Ethical approval and consent to participate
               All participants signed a written informed consent document in which they agreed to authorize access of the
               study team to their clinical data. The Committee for the Protection of Human Subjects at UTHealth
               Houston reviewed and approved the study protocol (HSC-MS-15-0120) on December 17, 2021.


               Consent for publication
               Not applicable.

               Copyright
               © The Authors 2023.


               REFERENCES
               1.       Kesler SR. Turner syndrome. Child Adolesc Psychiatr Clin N Am 2007;16:709-22.  DOI  PubMed  PMC
               2.       Cui X, Cui Y, Shi L, Luan J, Zhou X, Han J. A basic understanding of Turner syndrome: incidence, complications, diagnosis, and
                   treatment. Intractable Rare Dis Res 2018;7:223-8.  DOI  PubMed  PMC
               3.       Gravholt CH, Andersen NH, Conway GS, et al; International Turner Syndrome Consensus Group. Clinical practice guidelines for the
                   care of girls and women with Turner syndrome: proceedings from the 2016 Cincinnati International Turner Syndrome Meeting. Eur J
                   Endocrinol 2017;177:G1-G70.  DOI  PubMed
               4.       Karila D, Donadille B, Léger J, et al. Prevalence and characteristics of gonadoblastoma in a retrospective multi-center study with
   36   37   38   39   40   41   42   43   44   45   46